Mostrar el registro sencillo del ítem

dc.contributor.authorCarrión Navarro, Josefa
dc.contributor.authorArgüelles, Alejandra
dc.contributor.authorMartínez-Gimeno, María Lara
dc.contributor.authorTovar Lozada, Alejandro
dc.contributor.authorAyuso Sacido, Ángel 
dc.contributor.authorBelda-Iniesta, Cristobal
dc.contributor.authorArnás-Rodríguez, Mercedes
dc.contributor.authorGarcía Romero, Noemí 
dc.date.accessioned2023-03-31T09:29:15Z
dc.date.available2023-03-31T09:29:15Z
dc.date.issued2022
dc.identifier.issn1874-2106spa
dc.identifier.urihttps://hdl.handle.net/10641/3313
dc.description.abstractBackground: The incidence of community and nosocomial candidiasis has dramatically increased in the last two decades. There are multiple treatments for this infection, but the toxicity of some and the induction of resistant strains require the development of new compounds. Objectives: With the aim of reducing the Candida population in the oropharyngeal cavity, we have formulated a toothpaste with VG-01 agent, composed of a mixture of carnosic acid (CA) and propolis (PP). Methods: We investigated the ability of VG-01 toothpaste to minimize and stabilize fungal presence in 21 patients diagnosed with clinical oropharyngeal candidiasis. Results: Our data indicate that VG-01 toothpaste showed an effect not only against the most frequent species of Candida, C. albicans, but also in the other species analyzed. 82% of patients stated that they would continue using it outside the study. Conclusion: Our data demonstrate that VG-01, composed of CA and PP is a potential antimycotic agent effective against the most common species that cause oropharyngeal candidiasis present in clinical practicespa
dc.language.isoengspa
dc.publisherThe Open Dentistry Journalspa
dc.rightsAtribución-NoComercial-SinDerivadas 3.0 España*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/es/*
dc.subjectOral healthspa
dc.subjectCandidaspa
dc.subjectOropharyngeal candidiasisspa
dc.subjectAntimycotic effectspa
dc.subjectAntifungalspa
dc.subjectToothpastespa
dc.titleA New Natural Antimycotic Agent is Effective Against Oropharyngeal Candidiasis: The VIPROCAN Study.spa
dc.typejournal articlespa
dc.type.hasVersionAMspa
dc.rights.accessRightsopen accessspa
dc.description.extent988 KBspa
dc.identifier.doi10.2174/18742106-v16-e2202010spa
dc.relation.publisherversionhttps://opendentistryjournal.com/VOLUME/16/ELOCATOR/e187421062202010/spa


Ficheros en el ítem

FicherosTamañoFormatoVer
e187421062202010.pdf987.2KbPDFVer/

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Atribución-NoComercial-SinDerivadas 3.0 España
Excepto si se señala otra cosa, la licencia del ítem se describe como Atribución-NoComercial-SinDerivadas 3.0 España